EUCTR2010-019160-37-DK进行中（未招募）1 期
Intralymfatisk specifik immunterapi - som ny behandlingsmetode til græspollenallergikere - ILIT
Allergiklinikken0 个研究点目标入组 57 人开始时间: 2010年5月4日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 57
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Græspollenallergiske patienter i alderen 18-60 år.
- •Positiv sygehistorie for græspollenallergi, positiv priktest og specifikke antistoffer i blodet mod græspollen.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Alder under 18 eller over 60
- •Helårlig rhinoconjunktivitis og eller svær astma (grad 3 og 4)
- •Patienter i behandling med betablokkere eller perorale glukokorticoider
- •Gravide / ammende.
- •Alvorlige immunpatologiske sygdomme, herunder HIV positive eller Hepatitis B/C-pos.
- •Alvorlige psykiske lidelser.
研究者
相似试验
已完成
2 期
Study to Asses Efficacy of Intralymphatic ImmunotherapyAllergyNCT01166269Rigshospitalet, Denmark44
尚未招募
不适用
Epicutaneous and / or intralymphatic immunotherapy for nasal allergyJapanese cedar pollinosisJPRN-UMIN000015278Osaka Medical College Otorhinolaryngology36
进行中（未招募）
1 期
Pollenvaccination in humans, via a lymph node, with doses up to 10 000SQ-U. .Patients with severe to moderate Allegic rhinitis.EUCTR2015-001259-63-SEDepartment of Clinical Science, Intervention and Technology, Karolinska Institute80
进行中（未招募）
1 期
Treatment with 3 drugs against sensitive neuropathiesEUCTR2019-000177-23-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
进行中（未招募）
1 期
Early immunotherapy with intravenous immunoglobulin, cyclophosphamide and methylprednisolone in patients with anti-Hu-associated paraneoplastic sensory neuropathy (NESPA).paraneoplastic sensory neuropathy with anti-Hu antibodiesMedDRA version: 20.0Level: PTClassification code: 10072106Term: Paraneoplastic neurological syndrome Class: 100000004852CTIS2023-506942-22-01Assistance Publique Hopitaux De Paris21